RAMM Pharma Corp. (CSE:RAMM)

Revenue by Segment

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018
Pharmaceuticals	3.36M	4.34M	5.07M	3.90M	4.12M
Total	3.36M	4.34M	5.07M	3.90M	4.12M

Revenue by Geography

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018
Uruguay	2.22M	2.78M	3.48M	3.58M	4.06M
Italy	-	146.35K	103.90K	21.75K	7.95K
Poland	1.14M	1.41M	1.48M	296.29K	-
Brazil	-	-	-	-	42.56K
Other Countries	-	-	-	-	2.33K
Total	3.36M	4.34M	5.07M	3.90M	4.12M

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 8, 2026

Data Sources Report a data error